Changing hepatitis A epidemiology in the European Union: new challenges and opportunities
Eurosurveillance·
- DOI
- 10.2807/1560-7917.es2015.20.16.21101
- PMID
- 25953274
- PMCID
- —
- OpenAlex
- W2323217730
- Study type
- Commentary
- Publisher
- European Centre for Disease Control and Prevention (ECDC)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The commentary calls for improved traveler education by healthcare providers and travel medicine services, evidence-based outbreak control guidance from ECDC, and comprehensive epidemiological and microbiological reporting to identify prevention opportunities.
Structured evidence summary
Research question
This perspective examines hepatitis A epidemiology, outbreak patterns, vaccination policies, and prevention opportunities across the European Union and European Economic Area.
Study design
Commentary presenting epidemiological surveillance data on hepatitis A cases, outbreaks, and vaccination policies in EU/EEA countries.
Population and setting
European Union and European Economic Area member states, with endemicity ranging from very low to intermediate.
Main findings
Notification rates have declined in recent decades, but vaccination uptake remains insufficient to offset growing susceptible populations. Large outbreaks continue to occur, with travel facilitating virus introduction and secondary transmission. Data on risk behaviors, exposure, and mortality remain scarce at the EU/EEA level.
Public-health relevance
The commentary calls for improved traveler education by healthcare providers and travel medicine services, evidence-based outbreak control guidance from ECDC, and comprehensive epidemiological and microbiological reporting to identify prevention opportunities.
Important limitations
This summary relies on the supplied single-article abstract and metadata. The original paper is required for decision-grade interpretation of the epidemiological trends, outbreak characteristics, and policy recommendations discussed.
GIDS interpretation
The article was classified under hepatitis A disease, transmission dynamics, travel medicine, and vaccination topics, reflecting its focus on travel-associated transmission risk and immunization policy in low-to-intermediate endemicity settings.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 7 auditable classifier relationships to diseases, places, topics, and study design.